Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
At the American Diabetes Association's 78th Annual Scientific Session, MD Mag spoke with Murray Stewart, MD, the executive vice president and head of research and development at Novelion Therapeutics, about his research into the hormone leptin—a major player in appetite and metabolism, with much that's still misunderstood about it—presented at the annual meeting.
In addition to speaking about how that's led to most of his research into the hormone, Stewart spoke about where the medical community's understanding of leptin has come since the 1990s, and whether or not it has positive benefits and for which patients. He also noted the need for a better understanding of its relationship with type 2 diabetes and other metabolic conditions, many of which may be driven by its mechanism of action.
https://www.mdmag.com/conference-co...ty-type-2-diabetes-other-metabolic-conditions
In addition to speaking about how that's led to most of his research into the hormone, Stewart spoke about where the medical community's understanding of leptin has come since the 1990s, and whether or not it has positive benefits and for which patients. He also noted the need for a better understanding of its relationship with type 2 diabetes and other metabolic conditions, many of which may be driven by its mechanism of action.
https://www.mdmag.com/conference-co...ty-type-2-diabetes-other-metabolic-conditions